HIF1A and ovarian carcinoma: miR-138 has also been found dysregulated in various tumor types, notably RCC [107], ovarian cancer [108], and oral cancer [109]; targeting HIF-1α, SOX2 and HIF-1α, or RhoC and ROCK2, respectively.